People: Zogenix Inc (ZGNX.O)

ZGNX.O on Consolidated Issue listed on NASDAQ Global Market

8.49USD
5 Feb 2016
Change (% chg)

$-0.41 (-4.61%)
Prev Close
$8.90
Open
$8.85
Day's High
$9.07
Day's Low
$8.49
Volume
240,489
Avg. Vol
386,664
52-wk High
$21.65
52-wk Low
$8.44

Search Stocks

Rhoads, Ann 

Ms. Ann D. Rhoads is Chief Financial Officer, Executive Vice President, Treasurer, Secretary of Zogenix, Inc., since March 2010. From 2000 to December 2009, Ms. Rhoads was the Chief Financial Officer for Premier, Inc., a healthcare service company, where she had responsibility for all areas of financial management, strategic planning, business development, information technology, and ethics and compliance. From August 1998 to 2000, Ms. Rhoads served as Vice President for strategic initiatives at Premier, where she was responsible for overseeing strategic investments, including a venture capital fund, as well as assisting Premier operating divisions with long range strategic planning. Prior to joining Premier, Ms. Rhoads held various positions at Sprout Group, a venture capital affiliate of Donaldson, Lufkin & Jenrette (now part of Credit Suisse First Boston), Bain & Company and Merrill Lynch Capital Partners (now known as Stonington Partners). Ms. Rhoads is currently a member of the board of directors of Globus Medical Inc. and Evoke Pharma, Inc. Ms. Rhoads received a B.S. from the University of Arkansas and an M.B.A. from the Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 485,342
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 364,568
Fiscal Year Total, USD 849,910

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks